Cargando…

IMPACT OF COVID-19 PANDEMIC ON DELAY OF CHILDHOOD CANCER DIAGNOSIS AND THE OUTCOMES IN A PEDIATRIC HEMATOLOGY/ONCOLOGY DEPARTMENT

OBJECTIVE: Restriction of access to healthcare during COVID-19 pandemic is undoubtedly a major problem for patients with cancer. Although childhood cancers are highly curable, it is obvious that diagnostic and treatment disruptions will lead to poor Results. In this study we investigated the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: CAKMAKCI, Selma, SARI, Neriman, ERDEM, Arzu YAZAL, OZDEMIR, Sonay INCESOY, OZYORUK, Derya, PARLAKAY, Aslınur OZKAYA, ILHAN, İnci ERGURHAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Editora Ltda. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529933/
http://dx.doi.org/10.1016/j.htct.2022.09.1229
_version_ 1784801580492521472
author CAKMAKCI, Selma
SARI, Neriman
ERDEM, Arzu YAZAL
OZDEMIR, Sonay INCESOY
OZYORUK, Derya
PARLAKAY, Aslınur OZKAYA
ILHAN, İnci ERGURHAN
author_facet CAKMAKCI, Selma
SARI, Neriman
ERDEM, Arzu YAZAL
OZDEMIR, Sonay INCESOY
OZYORUK, Derya
PARLAKAY, Aslınur OZKAYA
ILHAN, İnci ERGURHAN
author_sort CAKMAKCI, Selma
collection PubMed
description OBJECTIVE: Restriction of access to healthcare during COVID-19 pandemic is undoubtedly a major problem for patients with cancer. Although childhood cancers are highly curable, it is obvious that diagnostic and treatment disruptions will lead to poor Results. In this study we investigated the effects of pandemic on diagnosis and treatment delays of children with cancer along with their consequences. METHODOLOGY: We searched all pediatric patients treated for cancer between March 2020 and January 2022 for COVID-19 infection. Data were collected collected from medical files of patients diagnosed with COVID-19, confirmed by polymerase chain reaction (PCR), who received active antineoplastic treatment. RESULTS: Fifty-eight patients developed COVID-19 infection at different stages of their anticancer treatment. Twenty-five had an asymptomatic COVID-19 infection, twenty-six had mild symptoms, three had moderate symptoms and four had severe disease. All of them recovered from COVID-19 infection. Chemotherapy courses were continued during active infection in four patients and interrupted in other patients. CONCLUSION: While strict measures are required to control the pandemic, patients with severe critical illness such as cancer should be carefully evaluated and treatment delays that may have vital consequences should be avoided. In pediatric patients with cancer whom infected by COVID-19, continuation of anticancer treatment may be considered by evaluating the clinical status of the patient.
format Online
Article
Text
id pubmed-9529933
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Editora Ltda.
record_format MEDLINE/PubMed
spelling pubmed-95299332022-10-04 IMPACT OF COVID-19 PANDEMIC ON DELAY OF CHILDHOOD CANCER DIAGNOSIS AND THE OUTCOMES IN A PEDIATRIC HEMATOLOGY/ONCOLOGY DEPARTMENT CAKMAKCI, Selma SARI, Neriman ERDEM, Arzu YAZAL OZDEMIR, Sonay INCESOY OZYORUK, Derya PARLAKAY, Aslınur OZKAYA ILHAN, İnci ERGURHAN Hematol Transfus Cell Ther Supportive Care and Palliative Care OBJECTIVE: Restriction of access to healthcare during COVID-19 pandemic is undoubtedly a major problem for patients with cancer. Although childhood cancers are highly curable, it is obvious that diagnostic and treatment disruptions will lead to poor Results. In this study we investigated the effects of pandemic on diagnosis and treatment delays of children with cancer along with their consequences. METHODOLOGY: We searched all pediatric patients treated for cancer between March 2020 and January 2022 for COVID-19 infection. Data were collected collected from medical files of patients diagnosed with COVID-19, confirmed by polymerase chain reaction (PCR), who received active antineoplastic treatment. RESULTS: Fifty-eight patients developed COVID-19 infection at different stages of their anticancer treatment. Twenty-five had an asymptomatic COVID-19 infection, twenty-six had mild symptoms, three had moderate symptoms and four had severe disease. All of them recovered from COVID-19 infection. Chemotherapy courses were continued during active infection in four patients and interrupted in other patients. CONCLUSION: While strict measures are required to control the pandemic, patients with severe critical illness such as cancer should be carefully evaluated and treatment delays that may have vital consequences should be avoided. In pediatric patients with cancer whom infected by COVID-19, continuation of anticancer treatment may be considered by evaluating the clinical status of the patient. Published by Elsevier Editora Ltda. 2022-10 2022-10-04 /pmc/articles/PMC9529933/ http://dx.doi.org/10.1016/j.htct.2022.09.1229 Text en Copyright © 2022 Published by Elsevier Editora Ltda. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Supportive Care and Palliative Care
CAKMAKCI, Selma
SARI, Neriman
ERDEM, Arzu YAZAL
OZDEMIR, Sonay INCESOY
OZYORUK, Derya
PARLAKAY, Aslınur OZKAYA
ILHAN, İnci ERGURHAN
IMPACT OF COVID-19 PANDEMIC ON DELAY OF CHILDHOOD CANCER DIAGNOSIS AND THE OUTCOMES IN A PEDIATRIC HEMATOLOGY/ONCOLOGY DEPARTMENT
title IMPACT OF COVID-19 PANDEMIC ON DELAY OF CHILDHOOD CANCER DIAGNOSIS AND THE OUTCOMES IN A PEDIATRIC HEMATOLOGY/ONCOLOGY DEPARTMENT
title_full IMPACT OF COVID-19 PANDEMIC ON DELAY OF CHILDHOOD CANCER DIAGNOSIS AND THE OUTCOMES IN A PEDIATRIC HEMATOLOGY/ONCOLOGY DEPARTMENT
title_fullStr IMPACT OF COVID-19 PANDEMIC ON DELAY OF CHILDHOOD CANCER DIAGNOSIS AND THE OUTCOMES IN A PEDIATRIC HEMATOLOGY/ONCOLOGY DEPARTMENT
title_full_unstemmed IMPACT OF COVID-19 PANDEMIC ON DELAY OF CHILDHOOD CANCER DIAGNOSIS AND THE OUTCOMES IN A PEDIATRIC HEMATOLOGY/ONCOLOGY DEPARTMENT
title_short IMPACT OF COVID-19 PANDEMIC ON DELAY OF CHILDHOOD CANCER DIAGNOSIS AND THE OUTCOMES IN A PEDIATRIC HEMATOLOGY/ONCOLOGY DEPARTMENT
title_sort impact of covid-19 pandemic on delay of childhood cancer diagnosis and the outcomes in a pediatric hematology/oncology department
topic Supportive Care and Palliative Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529933/
http://dx.doi.org/10.1016/j.htct.2022.09.1229
work_keys_str_mv AT cakmakciselma impactofcovid19pandemicondelayofchildhoodcancerdiagnosisandtheoutcomesinapediatrichematologyoncologydepartment
AT sarineriman impactofcovid19pandemicondelayofchildhoodcancerdiagnosisandtheoutcomesinapediatrichematologyoncologydepartment
AT erdemarzuyazal impactofcovid19pandemicondelayofchildhoodcancerdiagnosisandtheoutcomesinapediatrichematologyoncologydepartment
AT ozdemirsonayincesoy impactofcovid19pandemicondelayofchildhoodcancerdiagnosisandtheoutcomesinapediatrichematologyoncologydepartment
AT ozyorukderya impactofcovid19pandemicondelayofchildhoodcancerdiagnosisandtheoutcomesinapediatrichematologyoncologydepartment
AT parlakayaslınurozkaya impactofcovid19pandemicondelayofchildhoodcancerdiagnosisandtheoutcomesinapediatrichematologyoncologydepartment
AT ilhaninciergurhan impactofcovid19pandemicondelayofchildhoodcancerdiagnosisandtheoutcomesinapediatrichematologyoncologydepartment